We are live on ! Find out more
NMRD

Nemaura Medical, Inc. Common Stock
NMRD

Delisted

NMRD was delisted on the 4th of January, 2024.

Back to rankings

5 hedge funds and large institutions have $97K invested in Nemaura Medical, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

362% more capital invested

Capital invested by funds: $21K → $97K (+$76K)

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$36.5K
2
Deutsche Bank
Deutsche Bank
Germany
+$29.9K
3
UBS Group
UBS Group
Switzerland
+$8.31K

Top Sellers

Rank Fund Capital Flow
1
WAS
WESPAC Advisors SoCal
California
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$36K +$36.5K +3,464 New
Deutsche Bank
2
Deutsche Bank
Germany
$35K +$29.9K +2,833 +449%
SC
3
Scotia Capital
Ontario, Canada
$13K – – –
UBS Group
4
UBS Group
Switzerland
$11K +$8.31K +788 +305%
CFGS
5
Concourse Financial Group Securities
Alabama
$2K – – –
WAS
6
WESPAC Advisors SoCal
California
– -$2K -323 Closed

NMRD Hedge Fund Activity: Q1 2019 in Review

5 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q1 2019, worth a combined $97K — up 362% from $21K a quarter earlier.

Fund positioning in NMRD was balanced in Q1 2019: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $36.5K. The largest seller was WESPAC Advisors SoCal, exiting entirely with an estimated $2K sold.

  • 5 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $97K of Nemaura Medical, Inc. Common Stock stock for Q1 2019, up 362% quarter-over-quarter.
  • 1 fund opened new Nemaura Medical, Inc. Common Stock positions in Q1 2019 and 1 closed out, a net change of 0 holders.
  • The largest Nemaura Medical, Inc. Common Stock buyer in Q1 2019 was Renaissance Technologies, an estimated $36.5K added.
  • The largest Nemaura Medical, Inc. Common Stock seller in Q1 2019 was WESPAC Advisors SoCal, an estimated $2K sold.

Based on aggregated 13F filings for Q1 2019.